Application 205331
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ADENOSINE | ADENOSINE | SOLUTION;INTRAVENOUS | 60MG/20ML (3MG/ML) | No | No |
| 002 | ADENOSINE | ADENOSINE | SOLUTION;INTRAVENOUS | 90MG/30ML (3MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55150-192 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-192 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-192 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-192 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-193 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-193 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-193 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |
| 55150-193 | Adenosine | Adenosine | AuroMedics Pharma LLC | ANDA | Current |